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Chronic tuberculosis represents a major health problem for one-third of the world’s population today. A key
question relevant to chronic tuberculosis is the physiological status of Mycobacterium tuberculosis during this
important stage of infection. To examine the molecular bases of chronic tuberculosis and the role of host
immunity in mycobacterial growth, we determined the mycobacterial transcriptional profiles during chronic
and reactivation phases of murine tuberculosis using in vivo microarray analysis (IVMA). Following 28 days
of aerosol infection, mycobacterial counts remained stable, although the bacilli were metabolically active with
a 50% active transcriptome. The expression of genes involved in lipid and carbohydrate pathways was
significantly enriched during the middle stage of chronic tuberculosis, suggesting a nutrient-rich microenvi-
ronment. A total of 137 genes were significantly regulated in mid-chronic tuberculosis (45 and 60 days)
compared to an early stage (14 days) of infection. Additional sets of genes, including the virulence regulator
virS, were up-regulated during the reactivation stage, indicating their possible roles in mycobacterial resur-
gence. Interestingly, a set of potential transcriptional regulators was significantly induced at the late stage of
chronic tuberculosis. Bioinformatic analysis identified a large number of genes that could be regulated by one
of the potential transcriptional regulators encoded by rv0348, including the sigF operon. Taken together, IVMA
provided a better definition of the transcriptional machinery activated during chronic and reactivation stages
of tuberculosis and identified a novel transcriptional regulator. A similar approach can be adopted to study key
stages of intracellular pathogens.
One-third of the world’s population is infected with Myco-
bacterium tuberculosis, the causative agent of human tubercu-
losis, with an annual death rate of more than 2 million (8).
Treatment regimens are effective in only 60 to 90% of patients
with persistent infection (14). In humans, tuberculosis can be
divided into three phases (28): an active phase, characterized
by initial replication of M. tuberculosis that triggers host cell-
mediated immunity; a chronic phase, in which infected indi-
viduals are not infectious, with undetectable levels of tubercu-
lous bacilli; and finally, a reactivation phase, which occurs in
10% of patients with an intact immune system. The reactiva-
tion rate is even higher for immune-suppressed individuals
(19). Both in vitro and in vivo models have been used to
investigate tuberculosis during the dormancy and reactivation
phases in humans. One of the first in vitro models of tubercu-
losis dormancy was established by Wayne (49, 50) and is based
on culturing M. tuberculosis under decreasing concentrations of
oxygen levels, creating a microaerophilic environment where
mycobacteria transform into a nonreplicating persistent form.
More in vitro models were developed to study chronic tuber-
culosis, and they have shown that the host microenvironment is
rich in reactive nitrogen intermediates (29, 48) but deficient in
nutrients necessary for bacterial survival (5), suggesting that
tuberculous bacilli persist in a metabolically inactive form. For
in vivo studies, the mouse model of chronic and reactivation
stages of tuberculosis was used to profile the immunological
responses activated during both phases (9, 34). Using an arti-
ficial-granuloma implant in mice, the DosR regulon was shown
to play a role in mycobacterial entry into the dormant phase,
with the involvement of relA (20). Unfortunately, the main
genetic bases of the mycobacterial conversion from the “dor-
mant” to the “replicating” phase in the lungs has remained
largely unknown. In this report, we communicate our efforts to
investigate both the chronic and reactivation phases of tuber-
culosis.
A key question relevant to tuberculosis is the physiological
status of M. tuberculosis during different stages of infection.
The work of different groups (27, 39) using quantitative PCR
on both the genomic and transcriptional levels indicated that
mycobacterial bacilli persist at a constant level with a very low
growth rate. However, many questions related to chronic tu-
berculosis remain unanswered. Does the low growth rate mean
that the bacilli are metabolically inactive? Can the mycobac-
terial bacilli sense the surrounding microenvironment? Also,
do mycobacterial bacilli adapt to the change in their microen-
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vironment following the change in host immunity? Previously,
the low growth rate of M. tuberculosis, the need to conduct
experiments under strict biosafety conditions, and its intracta-
ble genetic system made deciphering chronic tuberculosis
problematic. Fortunately, the availability of the M. tuberculosis
whole-genome sequence and the development of several pro-
tocols designed to examine M. tuberculosis during in vivo
growth (20, 33, 42) have allowed great strides in tuberculosis
research. A recent analysis of the early stages of tuberculosis
on a genome-wide level revealed several sets of genes that are
specifically activated during lung infection of immune-compe-
tent mice, while other sets of genes were activated in immune-
compromised mice (43). Another transcriptional profiling of
infected human lungs portrayed a bacillus transcribing hun-
dreds of unique genes, depending on the site of sample isola-
tion (31).
To address some of the questions raised above, we adapted
a DNA microarray-based protocol (43) to profile the transcrip-
tome of M. tuberculosis during the chronic and reactivation
stages of tuberculosis in mouse lungs. Our analysis indicated
that despite the stability of mycobacterial colonization levels
during chronic tuberculosis, the bacilli remained metabolically
active, especially during the middle phase of chronic tubercu-
losis. A set of potential transcriptional regulators were identi-
fied throughout the examined times, with much higher levels of
induction during the late stage of chronic infection. One of the
transcriptional regulators (encoded by rv0348) was also shown
to bind to its own putative promoter sequence and potentially
to regulate several other genes that could be involved in es-
tablishing chronic tuberculosis. Finally, the analysis employed
identified a set of genes (n  174) that was specifically regu-
lated during the reactivation stage of tuberculosis, including a
well-studied virulence regulator, virS (17).
MATERIALS AND METHODS
Mouse infection. BALB/c mice (21 to 28 days old) purchased from Harlan
(Indianapolis, IN) were infected with 102 CFU/animal via intranasal instillation
or inhalation using the Glas-Col inhalation system (Glas-Col, LLC, Terre Haute,
IN). Within 4 h postinfection (p.i.), lung tissues were collected from two mice to
verify the exact infectious dose, and the two methods of infection yielded com-
parable colony counts. At designated times p.i. (28, 45, and 60 days), lung tissues
were harvested from groups of infected mice (n  50) using established protocols
(43). For the reactivation experiment, some groups were injected daily with
dexamethasone (0.1 mg/day) for 7 or 15 days starting at 45 days p.i. according to
earlier protocols (34, 47). At 52 and 60 days p.i., lung tissues were harvested and
subjected to RNA extraction and subsequent DNA microarrays. For each exam-
ined time, histopathology and colony counts of the harvested tissues (lung, liver,
and spleen) were performed as described previously (43, 44).
RNA extraction. To isolate mycobacterial RNA, lung tissues used for DNA
microarrays were harvested and placed directly onto dry ice. The lungs from each
group of four mice were rapidly homogenized in 20 ml of chilled 0.01% sodium
dodecyl sulfate (SDS), followed by filtration through a nylon wool column to
remove large tissue particles. The filtrates were collected in 50-ml Falcon tubes
(chilled in ice) and centrifuged at 4,000 rpm and 4°C for 10 min to collect
bacterial pellets released from disrupted cells. Additionally, mycobacterial cul-
tures started from the same seed (1:100 dilutions of bacteria frozen at mid-log
phase) were allowed to grow in Middlebrook 7H9 broth supplemented with 10%
albumin-dextrose complex. Culture samples were collected after 28, 45, and 60
days postinoculation for total RNA extraction to serve as comparison points for
the in vivo-growing mycobacteria. Total RNA was extracted from bacterial pel-
lets (harvested from cultures or lungs) using Tri-Zol reagent (Gibco) and zirco-
nium beads in a bead beater unit (three pulses for 30 seconds each) (BioSpec
Products, Inc., Bartlesville, OK) (42). For real-time quantitative PCR analysis,
lungs from a small number of infected animals (n  10) were harvested and
placed directly onto RNALater (Ambion, Austin, TX), an RNA stabilizer, before
homogenization and RNA extraction as described above.
Microarray hybridization. Extracted total-RNA samples were used in a stan-
dard reverse transcriptase reaction in the presence of M. tuberculosis genome-
directed primers (mtGDPs) (41). Briefly, RNA samples (10 to 15 g) were
labeled using CyScribe post-labeling kits (GE Healthcare Life Sciences, Piscat-
away, NJ) as described in the manufacturer’s manual, with the exception of using
6 l of mtGDPs (250 ng/l) to prime the transcription reactions instead of using
random primers. Mycobacterial genomic DNA (gDNA) was labeled using a nick
translation kit from Promega (Madison, WI) according to the manufacturer’s
protocol. The unincorporated nucleotides were removed from the labeled sam-
ples using QiaQuick PCR purification kits (QIAGEN, Inc., Valencia, CA). The
Cy3-labeled cDNA samples were cohybridized with the Cy5-labeled gDNA to
oligonucleotide DNA microarrays (Operon Technologies; Tuberculosis set ver-
sion 1.1) (41) designed from the genome sequence of M. tuberculosis H37Rv (11).
Following incubation at 67°C for 12 to 16 h, the hybridized slides were washed for
5 min at room temperature in low-stringency wash buffer (1 SSC [1 SSC is
0.15 M NaCl plus 0.015 M sodium citrate]-0.1% SDS), followed by a 3-min wash
in high-stringency buffer (0.1 SSC). Centrifuge-dried slides were scanned using
a GenPix 4.0B laser scanner (Molecular Devices Corp., Sunnyvale, CA) to
generate 16-bit TIFF images representing signal intensities of both cDNA and
gDNA. Hybridization signals from cDNA samples were compared to the hybrid-
ization signals generated from gDNA samples to estimate the relative gene
expression levels (41). Employing such a protocol for normalizing gene expres-
sion levels (termed genomic normalization) proved to be superior to other
protocols that use RNA or spiked-sample normalization (41, 51). Simple ratios
from single hybridizations were converted to logarithmic scale before a subse-
quent Lowess normalization protocol was employed (GeneSpring 7.0; Agilent
Technologies, Santa Clara, CA). A total of five to eight hybridizations were
analyzed for each RNA sample, extracted from two repeated biological samples.
The significance of differences in gene expression levels was tested using a
nonparametric test, such as Kruskall-Wallis (P  0.05), after applying the false-
discovery rate correction protocol to normalize for multiple-comparison testing.
Normalized gene expression levels were analyzed using a hierarchical cluster
algorithm (12) to identify the temporal changes in transcripts associated with
samples collected at different times p.i. (The Institute for Genomic Research;
MeV 4.0 [http://www.tm4.org/]).
Real-time quantitative PCR. For real-time quantitative PCR, total-RNA sam-
ples were treated with RNase-free DNase I (Ambion, Austin, TX) for 1 h at 37°C
before undergoing a standard reverse transcription reaction in the presence of
mtGDP as outlined previously (41). The generated cDNA served as a template
for quantitative PCR in the presence of gene-specific primers (see Table S1 in
the supplemental material) and SYBR Green dye (35, 36). For each amplifica-
tion run (iCycler thermocycler; Bio-Rad), the calculated threshold cycle (CT) for
each gene amplicon was normalized to the CT of the 16S rRNA gene (amplified
from the same sample) before calculating the change from in vivo/in vitro
samples at different times. The following formula was used to estimate change:
change (n-fold)  2CT, where CT for gene j was equal to (CT,j 
CT,16srRNA)in vivo  (CT,j  CT,16srRNA)in vitro. The melting curves for all reac-
tions were examined to identify primer-dimer formation and to ensure the
uniformity of the amplicons of all the genes.
Sequence analysis. The BLAST algorithm (2) was used to search the nonre-
dundant GenBank protein database for proteins similar to Rv0348. An E score
of 0.05 was used as the cutoff value for similar sequences. To identify potential
binding sites for the Rv0348 protein, the pattern search algorithm provided by
the TubercuList website (http://genolist.pasteur.fr/TubercuList/) was used, allow-
ing for two or three mismatches for either 35 or 10 regulatory sequences.
Searches included the first 900 bp upstream of each gene, in addition to the first
100 bp following the start codon. The search strategy included a 1,000-bp cutoff
limit to accommodate genes that were members of operons.
Protein purification and electrophoresis mobility shift assay (EMSA). Clon-
ing, protein production, and purification were described in detail previously (4).
Briefly, a maltose binding protein (MBP) fusion of M. tuberculosis Rv0348 was
constructed in Escherichia coli using the pMAL-c2 vector (New England Biolabs,
Beverly, MA). The MBP-Rv0348 protein was then overexpressed by induction
with 0.3 mM isopropyl-	-D-thiogalactopyranoside (Sigma, St. Louis, MO) and
purified by affinity chromatography using an amylose resin supplied by New
England Biolabs. The expression of mycobacterial fusion proteins was monitored
with GelCode Blue (Pierce Biotechnology Inc., Rockford, IL)-stained SDS-
polyacrylamide gel electrophoresis gels. Selected fractions eluted from the amy-
lose resin column were pooled and dialyzed using Slide-A-Lyzer cassettes (Pierce
Biotechnology Inc.) in 1.5-liter phosphate-buffered saline (150 mM NaCl, 10 mM
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NaPO4, pH 7.4), with three exchanges at 4°C. The purified protein aliquots were
stored at 20°C.
For EMSA, probes were generated by PCR amplifications. PCR primers were
designed with Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www
.cgi) by providing the upstream probable regulatory sequences of selected genes.
PCR amplicons were analyzed on 2% agarose gels and then purified with the
Wizard SV Gel and PCR Clean-Up System (Promega). The purified DNA
fragments (3.5 pmol) were end labeled with 10 U of T4 polynucleotide kinase
(Promega) and 10 Ci of [
32-P]ATP (Perkin-Elmer, Wellesley, MA) at 37°C for
10 min. Various amounts of the purified proteins and probes were incubated in
EMSA binding buffer (20 mM KCl, 5% glycerol, 25 mM Tris-HCl, pH 8.0, 0.5
mM EDTA, 0.5 mM dithiothreitol, and 10 ng/ml herring sperm DNA) at 25°C
for 10 min in a total volume of 10 l. The mixtures were resolved on 4% native
polyacrylamide gels that were subsequently dried and exposed to X-ray films
(Kodak, Rochester, NY).
RESULTS
Persistent infection with M. tuberculosis. Our working defi-
nition of chronic tuberculosis is the presence of a constant level
of mycobacterial bacilli in the host organs while the host ap-
pears relatively healthy, reflecting an equilibrium between the
host and M. tuberculosis (13). Generally, mice infected with a
low dose of aerosolized M. tuberculosis develop a persistent
infection by 28 days p.i., which continues for prolonged times
(300 days) (21). Before conducting microarray analysis of M.
tuberculosis-infected mice, we examined organ colonization
levels to test the feasibility of isolating enough mycobacterial
RNA for microarray analysis. A protocol for a low-dose aero-
solization (32) with the virulent strain H37Rv was used to
mimic natural infection in humans. As expected, colony counts
of M. tuberculosis in organs were higher at 21 and 28 days p.i.
than at later times (60, 120, and 140 days p.i.) (see Fig. S1 in
the supplemental material). Analysis of the bacterial load of
lung tissues following the initial infection indicated the pres-
ence of sufficient mycobacterial bacilli (106 CFU/g) suitable
for transcriptional analysis. Generally, the level of bacterial
colonization remained almost unchanged in all organs (liver,
spleen, and lung) from 60 days onward, indicating the transi-
tion from active to chronic stages of infection. Histological
examination of M. tuberculosis-infected mouse tissue collected
at different times p.i. showed signs of tuberculosis progression
for aggregates of lymphocytes and macrophages (at early
stages, i.e., 21 and 28 days p.i.) to a more organized inflam-
matory response with the presence of foamy macrophages (at
later times, e.g., 140 days p.i.). At all times examined, acid-fast
bacilli were seen in lung sections, while their numbers per
microscopic field declined over time. Both the colony counts
and the histological findings proved that persistent tuberculosis
was established in mice following low-dose (102 CFU) aero-
solization. Because this stage of infection spans a long time,
generally between 20 and 300 days p.i., we and others (16,
32) further divide the chronic phase of tuberculosis into early,
middle, and late stages based on histological changes observed
in animals (see Fig. S1 in the supplemental material). Subse-
quent analyses described here are focused on the middle stage
of chronic tuberculosis (45 and 60 days p.i.), using DNA mi-
croarrays. The late stage (140 days p.i.) of chronic tuberculosis
was analyzed using real-time PCR to accommodate the small
amount of mycobacterial RNA isolated at that stage.
IVMA during chronic tuberculosis. To profile the expression
levels of mycobacterial genes as the bacilli enter the chronic
stage of tuberculosis, total RNA was isolated from M. tuber-
culosis directly following its harvesting from lungs of infected
mice (43). Using genome-directed primer technology (42),
RNA samples collected at 28, 45, and 60 days p.i. were pro-
cessed for DNA microarrays in comparison to mycobacterial
cultures grown in Middlebrook 7H9 broth, which were sam-
pled 28, 45, and 60 days after inoculation. The quality of the
hybridization signals was assessed using scatter plot analysis of
sample replicates and by calculating the coefficient of variance
(CV) as suggested previously (46) (Fig. 1A and B). Sample
hybridizations with high correlation levels (P  0.9) among
replicates were used for downstream analysis. Almost 18% of
the hybridization experiments (out of 56 hybridizations used
throughout this project) were excluded from analysis because
of low correlation levels among replicates. Additionally, genes
with a CV of 1 within each group of replicates (0.3 to 1% of
the genes), indicating low reproducibility, were also excluded
from downstream analysis. Finally, to examine the overall per-
formance of DNA microarrays to estimate gene expression
levels from BALB/c samples, a randomly chosen set of genes
(n  21) were selected for real-time PCR analysis (36). Such
analysis included genes with either induced or repressed levels.
An agreement in induction or repression of 86% of the genes
was obtained when IVMA and real-time PCR expression levels
were compared (see Table S1 in the supplemental material).
To compare gene transcripts in a large number of replicates
(six to eight replicates/time point) among several times follow-
ing infection, we employed a genomic normalization protocol
that was able to accurately profile the transition in mycobac-
terial transcripts during growth from log to stationary phases
(41). In this protocol, each Cy3-labeled sample derived from
RNA was cohybridized with Cy5-labeled gDNA extracted from
M. tuberculosis H37Rv, the same strain used for animal infec-
tions. Generally, genes were considered transcribed only when
they passed all of the filters described above and when the
normalized signal intensity generated from the labeled cDNA
was equal to or more than that generated by gDNA hybridiza-
tion (i.e., the primary cDNA/gDNA ratio was 1). Also, to
compute the change in gene transcripts, the ratios of the pri-
mary ratios were compared among different samples.
Analysis of the overall change in the number of mycobacte-
rial transcripts identified a unique global pattern that needs to
be highlighted. Contrary to the IVMA of active tuberculosis,
where transcription levels were detected in 75% of the genes
at 14 days (43), IVMA of the middle phase of chronic tuber-
culosis (45 and 60 days p.i.) detected hybridization signals in
50% of the genes transcribed during growth in BALB/c mice
compared to only 43% for in vitro cultures (Fig. 1C and D).
The change in gene transcripts did not reach statistical signif-
icance for all genes with detectable levels. In fact, only 299
genes (7.6%) were significantly changed among in vivo
(BALB/c) compared to in vitro (7H9 broth) samples during the
progression to the middle phase of chronic tuberculosis (see
Table S2 in the supplemental material). The main goal of such
analysis is to identify genes activated solely during infection but
not during in vitro growth. Compared to the in vitro cultures at
45 days p.i., the significantly up-regulated genes in BALB/c
mice included genes involved in the biosynthesis of peptidogly-
can (glmU) and lipid hydrolysis (lipM), as well as stringent
stress response (lytB2). At 60 days p.i., mycobacterial genes
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involved in glycolysis (fba), thiamine biosynthesis (thiE), and
base excision repair (ung) were up-regulated in mice.
A unique transcriptional profile for chronic tuberculosis. To
further identify unique patterns of gene expression associated
with mycobacterial growth in the murine lung, we employed a
hierarchical clustering algorithm (12). The applied algorithm
portrayed a distinctive pattern of gene expression of M. tuber-
culosis growing in mouse lungs compared to those bacilli grow-
ing in vitro (Fig. 2A; see Table S3 in the supplemental mate-
rial). Additionally, transcripts from bacilli growing at later
times (45 and 60 days) within each cluster (in vitro or in vivo)
were closely related to each other compared to the profile of
28-day samples, implying the transition of the tuberculous ba-
cilli to the chronic stage. Again, this pattern confirms the
overall similarity between 45- and 60-day samples. Some of the
clusters included groups of genes with higher expression levels
during survival in BALB/c mice than during growth in vitro.
One of these clusters included genes involved in the Krebs
cycle (icd2) and arginine metabolism (rocD2 and adi) as well as
peptidoglycan metabolism (glmU). In another cluster, the po-
tential transcriptional regulator rv0348 was coexpressed with
other genes, such as those involved in lipid transfer across the
mycobacterial membrane (ltp1), sialic acid transfer (nanT),
aerobic respiration (glpD1), and lipid degradation (fad16).
The metabolic state of M. tuberculosis during chronic infec-
tion. A major objective of the IVMA of chronic tuberculosis is
to assess the physiological status of mycobacterial bacilli as
they enter this important phase of the infection. We consid-
ered bacilli metabolically active when the majority of the genes
in key metabolic pathways, such as carbohydrate, ATP synthe-
sis, and energy pathways, were transcribed. Such criteria were
suggested earlier for M. tuberculosis (18, 40). Accordingly, we
analyzed the list of transcribed genes (primary ratio, 1) to
identify their participation in metabolic pathways already
known for M. tuberculosis compiled by the KEGG encyclope-
dia (http://www.genome.ad.jp/kegg/kegg2. html). Using Fish-
er’s exact test (1, 22), the significant enrichment of certain
pathways was identified among the total number of transcribed
genes (Table 1). Among the significantly enriched pathways
(P  0.05) are those involved in carbohydrate metabolism
(e.g., the citrate cycle and starch and sucrose groups), lipid
metabolism (e.g., fatty acid metabolism), and energy metabo-
lism (e.g., oxidative phosphorylation and sulfur metabolism).
Other significantly enriched pathways included those respon-
sible for processing genetic information (e.g., DNA polymer-
ase) or responding to environmental stimuli (e.g., two-compo-
nent signal transduction). Overall, more than 50% of the genes
involved in the metabolic pathways listed in Table 1 were
represented in samples analyzed in the middle phase of chronic
tuberculosis (45 or 60 days p.i.). The active transcription of
genes represented by these pathways indicates metabolically
active bacilli that can utilize both carbohydrate and lipid
sources to generate the necessary energy for carrying on
cellular processes or responding to the surrounding micro-
environment.
Transcriptional profile of the middle stage of chronic tuber-
culosis. Since we previously analyzed the transcriptional pro-
file of early chronic tuberculosis (28 days p.i.) in comparison to
active tuberculosis (43), we decided to focus further analysis on
the middle and late stages. To identify unique genes important
for the mid-chronic stage of tuberculosis, we compared the
expression profile of the 45- and 60-day-p.i. samples to the
expression profile of samples collected during the active stage
of tuberculosis (14 days p.i.) that was reported earlier (43).
Although we did not expect significant change in the transcrip-
tional machinery of M. tuberculosis during progression from 45
FIG. 1. Transcriptional profile of M. tuberculosis during early and middle stages of chronic tuberculosis. (A) A sorted dot plot displaying the
CV of genes with detectable levels of gene expression in BALB/c mice at 45 days p.i. (B) A sorted dot plot displaying the CV of genes with
detectable levels of gene expression in BALB/c mice at 60 days p.i. (C) Transcriptional profile of M. tuberculosis growing in 7H9 broth (bars) and
CFU counts (line graph) at 28, 45, and 60 days p.i. (D) Transcriptional profile of M. tuberculosis growing in BALB/c mouse lungs (bars) and CFU
counts (line graph) at 28, 45 and 60 days p.i. The error bars indicate standard deviations.
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to 60 days, we included both times to provide a higher-resolu-
tion analysis of the middle stage of chronic tuberculosis. In
fact, only five genes (glf, narK2, rv0188, rv1738, and rv2672)
were significantly changed between 45- and 60-day samples,
confirming that both times could represent the middle stage of
chronic tuberculosis. However, a total of 88 and 49 mycobac-
terial genes were significantly changed when 14-day samples
were compared to samples collected from mice infected for 45
or 60 days p.i., respectively. Interestingly, most of the signifi-
cantly changed genes (90%) were up-regulated at later times
compared to the 14-day-p.i. samples (see Table S2 in the sup-
plemental material). Among the significantly up-regulated
genes at later times were those genes encoding the glycoxolate
shunt functions (icl and aceAa) (26) and histidine biosynthesis
(hisS), as well as the transcriptional regulator sigK (24). Cor-
relation analysis of gene expression levels further identified a
small group of genes that displayed consistent transcription
profiles at all time points examined (Table 2). Some of these
genes were always induced in mice compared to 7H9 broth
(e.g., mprA, lppJ, and rv0348) or always repressed (e.g., accD4
and rv3830c). The mprA gene encodes a transcriptional regu-
lator that plays a role in establishing chronic infection that was
described earlier using a deletion mutagenesis approach (52,
53), as well as using IVMA (43). The rv3830c gene encodes
another putative transcriptional regulator that could play a
role as a transcriptional repressor (http://genolist.pasteur.fr
/TubercuList/).
Transcriptional profile of M. tuberculosis during immune
suppression. An important phase of human tuberculosis is the
reactivation of the tuberculous bacilli after exposure to im-
mune suppression. To profile the change in gene expression
levels of M. tuberculosis undergoing reactivation, groups of
BALB/c mice were inoculated daily with dexamethasone for 7
or 15 days starting at 45 days p.i., i.e., during the middle phase
of chronic tuberculosis. Colony counts from lung tissues at 52
and 60 days p.i. displayed an increase in mycobacterial counts
in the lungs of the dexamethasone-treated group (5.6  107
CFU/lung) compared to the untreated control group (1  107
CFU/lung). To identify the overall change in the mycobacterial
expression profile following immune suppression, hierarchical
FIG. 2. Expression profile of M. tuberculosis in mice during chronic and reactivation stages of infection. (A) A two-dimensional hierarchical
cluster analysis of expression levels of M. tuberculosis H37Rv genes growing in 7H9 Middlebrook broth or in BALB/c mice at different times after
aerosol infection (28, 45, and 60 days p.i.). One example of a gene cluster with down-regulated genes in all in vivo samples is presented. (B) A
two-dimensional hierarchical cluster analysis of gene expression levels of M. tuberculosis growing in 7H9 Middlebrook broth or in BALB/c mice
at 28, 45, 52, and 60 days p.i. One example of a cluster with up-regulated genes in all in vivo samples is presented. The red and green boxes denote
up- or down-regulation, respectively.
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cluster analysis was used to organize expression levels into
groups based on their levels of induction or repression. Al-
though colony counts of the dexamethasone-treated groups
displayed a modest increase in bacterial load, IVMA was able
to identify clusters of genes that were differentially expressed
in dexamethasone-treated samples (Fig. 2B). Moreover, sam-
ples collected from in vitro cultures or BALB/c mice and dexa-
methasone-treated mice occupied distinct nodes of the cluster,
indicating the sensitivity of the IVMA to profile the overall
change in gene expression. Some of the genes up-regulated
during the dexamethasone treatment were also up-regulated in
samples collected from infected but untreated mice (e.g., glmU
and ung). However, some genes were activated only during
dexamethasone treatment, including virS (Fig. 2B) and mem-
bers of the mce family of proteins. Overall, a total of 174 genes
(see Table S4 in the supplemental material) occupied the same
cluster and were up-regulated during the reactivation phase of
tuberculosis.
An interesting feature of the genes activated during reacti-
vation is the inclusion of several transcriptional regulators
other than VirS. Some of these transcriptional regulators are
members of the signal transduction protein kinase (STP-K)
family involved in signal transduction through phosphorylation
(pknB and pknG). It is possible that pknB is involved in cell
division, while pknG could be involved in regulating amino
acid uptake and stationary-phase metabolism (7). Another
transcriptional regulatory protein (phoY1), responsible for
transporting phosphate ions, was also activated during dexa-
methasone treatment. Another group of reactivation-specific
genes included those responsible for iron-sulfur transport
(fdxC), sulfur transferase (cysA2), and sulfite synthesis (cysQ),
indicating the importance of both iron and sulfur metabolism
to M. tuberculosis during reactivation. Interestingly, genes ex-
pected to be activated during the mycobacterial active stage of
growth were also differentially activated during dexamethasone
treatment, such as those involved in hydrolysis of peptide
bonds (pepB and pepE), redox reactions (trxB1), and trehalose
and mycolic acid biosynthesis (glgY and pcaA). Overall, a
unique set of genes were activated as a consequence of mouse
exposure to immunosuppressant, reflecting the surge in myco-
bacterial growth during the reactivation phase of tuberculosis.
TABLE 1. Metabolic pathways transcribed in BALB/c mice at 45 or
60 days post-aerosol infection with M. tuberculosis H37Rv
Metabolic pathwaya No. of genes/pathway
Total no. of
transcripts P value
b
Whole genome 762 2,855
1- and 2-methylnaphthalene
degradation
57 44 0.04289
ABC transporters 107 79 0.00037
Alanine and aspartate
metabolism
17 12 0.05764
Aminoacyl-tRNA biosynthesis 22 16 0.05462
Aminosugar metabolism 10 9 1.00000
Arginine and proline
metabolism
28 24 0.77532
ATP synthesis 8 8 0.60675
Biosynthesis of siderophore,
nonribosomal peptides
9 8 1.00000
Biotin metabolism 14 11 0.40938
Carbon fixation 13 10 0.22790
Citrate cycle (tricarboxylic acid
cycle)
30 22 0.04761
DNA polymerase 11 5 0.00119
Fatty acid biosynthesis 13 10 0.22790
Fatty acid elongation 2 2 1.00000
Fatty acid metabolism 39 28 0.01288
Folate biosynthesis 20 15 0.16698
Glycolysis gluconeogenesis 31 23 0.05211
Glyoxylate and dicarboxylate
metabolism
15 13 1.00000
Nucleotide sugar metabolism 18 12 0.02135
One-carbon pool by folate 12 10 0.65930
Oxidative phosphorylation 37 23 0.00013
Peptidoglycan biosynthesis 13 11 0.67817
Phenylalanine, tyrosine, and
tryptophan biosynthesis
26 22 0.56691
Ribosome 55 48 1.00000
Starch and sucrose metabolism 25 18 0.03443
Sulfur metabolism 11 9 0.64181
Tryptophan metabolism 65 50 0.02336
Two-component system 54 35 0.00003
Urea cycle and metabolism of
amino groups
16 12 0.14037
a Based on KEGG website (http://www.genome.ad.jp/kegg/pathway.html).
b Fisher’s test (http://home.clara.net/sisa/fisher.htm). Significant values are in
boldface.
TABLE 2. Change in expression levels of mycobacterial genes with similar expression patterns in samples collected from
mice relative to 7H9 broth
Gene Product Annotationa
Change (n-fold)  SD at (days):
28 45 60
rv0156 PntAB Nicotinamide nucleotide transhydrogen subunit 2.72  0.27 1.87  0.22 1.57  0.31
rv0348 Rv0348 Possible transcriptional regulator, TetR/AcrR family 1.59  0.25 1.49  0.11 1.67  0.36
rv0981 MprA Two-component response regulator 4.83  2.25 2.26  0.39 9.51  5.17
rv1062 Rv1062 Unknown conserved protein 3.67  0.2 2.77  0.15 1.99  0.31
rv2080 LppJ Possible lipoprotein 3.43  0.33 2.74  0.22 2.13  0.37
rv2326c Rv2326c Putative ABC transporter 3.36  0.26 2.95  0.19 2.67  0.56
rv3079c Rv3079c Unknown conserved protein 2.51  0.57 2.58  0.6 3.24  1.19
rv3103c Rv3103c Proline-rich proteins of unknown function 3.15  0.96 3.42  0.96 3.08  0.8
rv3685c Rv3685c Probable cytochrome P-450 2.3  0.55 2.17  0.4 2.98  0.84
rv3799c AccD4 Probable propionyl-coenzyme A carboxylase 3.49  0.49 2.96  0.4 3.58  1.07
rv3830c Rv3830c Transcriptional regulator protein 1.87  0.38 1.92  0.42 1.74  0.29
rv3871 Rv3871 Unknown conserved protein 2.6  0.48 2.44  0.58 2.85  0.71
a Tuberculist website (http://genolist.pasteur.fr/TubercuList/).
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Expression analysis of selected genes at the late stage of
chronic tuberculosis. The IVMA of mycobacterial transcripts
identified genes with unique profiles that could be responsible
for mycobacterial survival during the middle stage of chronic
tuberculosis. We reasoned that if these genes are important for
establishing mycobacterial persistence, they will continue their
trend of activation at later times of tuberculosis beyond 60 days
p.i. (the late chronic stage). To examine this hypothesis, the
transcriptional levels of selected mycobacterial genes were an-
alyzed using real-time quantitative PCR in samples collected
from a small number of mice infected for 20 weeks (140 days
p.i.) compared to samples collected following 20 and 60 days of
infection. For real-time quantitative PCR, genes were selected
based on information gleaned from their sequence analysis or
because they represented groups of significantly changed
genes. The list of selected genes included representative mem-
bers of the in vivo-expressed genomic island (iVEGI) gene
group (rv0967 and rv0990c) (43), genes identified in unique
clusters (rv0348, rv1873, and mutT1), or those that were sig-
nificantly regulated among in vivo and in vitro samples (cobI,
clpX, and adi) at 45 and 60 days p.i. (see Table S7 in the
supplemental material). As expected, most of the selected
genes were up-regulated in 20-week (140-day-p.i.) samples
compared to 20- and 60-day-p.i. samples (Table 3), indicating
a difference in the bacterial transcripts at the active compared
to the middle and late stages of chronic tuberculosis. Interest-
ingly, the putative transcriptional regulator rv0348 was up-
regulated at a much higher level at 20 weeks p.i.
Transcriptional control of chronic tuberculosis. Because of
the high induction of rv0348 in samples collected in late tu-
berculosis and based on the preliminary annotation of this
gene as a transcriptional regulator, we analyzed the rv0348
gene sequence to examine its potential role during chronic
tuberculosis. Analysis of the secondary sequence structure of
amino acid residues encoded by rv0348 indicated the presence
of a helix-turn-helix domain of 21 residues among the 217
amino acid residues (Fig. 3A). This helix-turn-helix domain
usually indicates DNA binding ability (25). BLAST analysis of
Rv0348 indicated the highly conserved nature of the protein in
mycobacterial species of the M. tuberculosis complex (100%
identity) and to a much lesser degree (55%) in the nonpatho-
genic strain of Mycobacterium smegmatis. Additionally, the
only significant similarity (P  6E19) between the Rv0348
sequence and other proteins outside the Mycobacteriaceae was
found in Nocardia farcinica, with 33% identity. Analysis of
rv0348 flanking sequences identified rv0348 as a member of an
operon (Fig. 3A) with unknown function.
We reasoned that if rv0348 encodes a potential transcrip-
tional regulator, it may encode a DNA-binding protein that
can bind to its own promoter. To test this hypothesis, we
expressed and purified the recombinant Rv0348 protein
(rRv0348) in E. coli. The binding ability of the purified protein
was tested against several probe constructs amplified from
different sites upstream of the rv0348 sequence by using EMSA
(Fig. 3B). As expected, EMSA analysis identified a stretch of
DNA for protein binding (148 bp) that was actually within 150
bp of the rv0348 operon, i.e., within the predicted rv0347 open
reading frame. Additionally, several concentrations of the
rv0347 probes were able to bind competitively to rRv0348, but
not to a putative promoter region in Mycobacterium paratuber-
culosis, confirming the specificity of rRv0348-DNA binding
(Fig. 3C). Using a promoter recognition algorithm, BPROM
(http://www.softberry.com/berry.phtml), we were able to pre-
dict a potential promoter binding site (TGGGTA-N[12]-GGG
TACAT) within the first 148-bp fragment from the start codon
of rv0347. The putative promoter sequence was used to search
the M. tuberculosis genome for other genes that could also be
under the control of Rv0348, using criteria similar to those
used to predict genes under the control of SigD (6). The search
pattern algorithm identified a list of 130 genes with a DNA
recognition sequence similar to the motif identified upstream
of the rv0348 coding sequence. Most of the motifs were present
in the 500 bp upstream of each identified gene (see Table S5 in
the supplemental material). Interestingly, some of the genes
identified in this analysis included the sigF operon, which is
known to orchestrate entry into the chronic stage of tubercu-
losis (10). Moreover, the sigF promoter consensus sequence
(15) was found to overlap with the putative promoter sequence
identified for rv0348, indicating possible regulation of rv0348
by the SigF protein itself.
DISCUSSION
The chronic phase of tuberculosis remains an understudied
stage of infection because of the inherent problems in isolating
enough bacteria for molecular analysis. For example, whether
mycobacterial bacilli survive in dormant or replicative forms is
not completely understood and remains a controversial issue
(30). In this report, we employed a novel protocol for IVMA to
profile the metabolic states of M. tuberculosis during the mid-
TABLE 3. Expression of a selected list of mycobacterial genes in mouse lungs using samples collected at 20 weeks compared to 20 days p.i.
Gene Reason for inclusiona
Change (n-fold)  SD at:
20 wk/20 days 20 wk/60 days
rv0967 Potential transcriptional regulator and iVEGI member 6.7  0.11 NDb
rv0990c Potential transcriptional regulator and iVEGI member 16.1  0.34 ND
rv1873 Induced in BALB/c mice compared to 7H9 broth at 60 days 122.8  0.69 84.6  0.66
mutT1 Induced in BALB/c mice compared to 7H9 broth at 45 days 3.0  0.28 24.9  0.45
rv0348 Potential transcriptional regulator activated at 60 days 200.8  1.00 68.4  0.01
cobI Significant between groups of BALB/c mice vs. 7H9 at 60 days 12.9  0.79 36.9  0.49
clpX Significant between BALB/c mice at 14 and 45 days 2.8  1.00 13.9  1.20
adi Significant between groups of BALB/c mice vs. 7H9 at 45 days 2.8  1.10 1.8  1.00
a Reason for inclusion based on this study and the bioinformatics analysis of the gene sequence.
b ND, not done.
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dle and late stages of murine tuberculosis. Interestingly, IVMA
revealed metabolically active bacilli despite a constant level of
mycobacterial colonization of the lung. The analyses presented
identify bacilli actively transcribing 50% of their encoded
genes, including those involved in several metabolic pathways
important for mycobacterial survival (e.g., the citrate cycle,
DNA polymerase, ATP synthesis, and nucleotide sugar metab-
olism). Such a finding suggests bacilli that are not metabolically
dormant, at least during the middle stage of chronic tubercu-
losis, the target stage for IVMA. Earlier studies used similar
criteria to assess mycobacterial metabolic activity (18, 40). Un-
fortunately, it is difficult to decipher whether pathways that are
not induced are actually repressed in mouse lungs or whether
they are beyond detectable levels because of the technical
limitations of IVMA. Among the genes activated during mid-
chronic tuberculosis are those that were also regulated during
active tuberculosis (43), including members of the iVEGI re-
gion. Some of these genes (e.g., rv0967 and rv0970) were also
activated in the artificial-granuloma model of tuberculosis
(20). Additional genes activated in murine lungs included
those encoding metalloregulatory proteins, such as rv0763c
(for iron metabolism) and mog (for molybdenum metabolism),
implying an important role played by metal ions in the patho-
genesis of chronic tuberculosis. Such a role for metals in my-
cobacterial pathogenesis has just been illustrated by our
group’s delineation of a novel transcriptional regulator (csoR)
(23). Because of the unique features of the mouse model of
chronic tuberculosis (maintenance of a constant but relatively
high level of M. tuberculosis) compared to natural infection,
further studies are needed before drawing conclusions on hu-
man tuberculosis based on the identified transcriptional pro-
files. For example, genes activated inside the typical human
granuloma, where M. tuberculosis encounters caseation and
anaerobic conditions, will be difficult to study in murine lungs,
which lack such conditions (45).
An interesting aspect of the IVMA reported here is the
identification of a group of genes that was coregulated at all
times examined during in vivo and in vitro growth of M. tuber-
culosis, including mprA, a known transcriptional regulator in-
volved in bacterial persistence (52, 53). This unique pattern of
expression implies an important role of these genes in regu-
lating mycobacterial entry into the chronic stage of infection.
Bioinformatics and protein analyses of one of the identified
genes, rv0348, indicated its potential regulation of a large num-
ber of genes, including sigF, the well-characterized sigma fac-
tor responsible for establishing chronic tuberculosis (15). It will
be interesting to decipher the interplay between proteins en-
coded by sigF and rv0348 during chronic infection. Experimen-
tal protocols (e.g., protein-DNA assays) are also needed to
confirm the role of Rv0348 in regulating genes identified by
bioinformatics analysis. Clearly, the IVMA approach also
helped to gain insights into the reactivation phase of tubercu-
FIG. 3. Transcriptional activities of in vivo-activated genes during chronic tuberculosis. (A) Organization of the rv0348 operon with the
secondary structure of the Rv0348 protein. (B) EMSA of the binding ability of rRv0348 or the MBP to an upstream region within the rv0347
sequence. (C) EMSA of the binding ability of rRv0348 in the presence of both specific (rv0347) and nonspecific (map2505) probes. 32P-labeled
probes were prepared by end labeling using T4 polynucleotide kinase. Protein-DNA complexes were resolved in 4% SDS-polyacrylamide gel
electrophoresis gels and exposed to X-ray films for 2 to 6 h before development. Probe names and concentrations are listed above each gel image.
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losis. Once the host immunity was repressed, a different profile
of M. tuberculosis emerged, characterized by the up-regulation
of several transcriptional regulators, such as the virS system
and several mammalian cell entry operons (the mce family).
The virS gene was shown to be involved in transcriptional
regulation of M. tuberculosis virulence (17), while the other
genes (lprK, mce2A, and mce4A) were shown to be involved in
cell invasion (3). Both functions could be necessary for the
reactivation phase of tuberculosis. It is possible that VirS could
be one of the master regulators involved in the reactivation of
tuberculosis. It is also possible that a different reactivation
profile would emerge if the time of immune suppression was
delayed beyond 45 days p.i. or if another model of reactivation
was attempted.
We also took advantage of the growing number of publica-
tions on mycobacterial expression profiling to compare expres-
sion levels obtained from the IVMA of mouse lungs to those
generated by in vitro models when M. tuberculosis was grown
under variable but defined stress conditions. The goal of this
comparative analysis is to “sketch” the main features of the
microenvironments where tuberculous bacilli reside. A num-
ber of significantly regulated genes inside mouse lungs were
also regulated during in vitro stimulation of M. tuberculosis,
using stress conditions, such as hypoxia (38), nutrient starva-
tion (5), exposure to nitric oxide (48), or survival inside the
macrophage microenvironment (37). Genes encoding proteins
involved in aerobic/anaerobic respiration (e.g., nuoC and
nuoL) and homologues for isocitrate lyase (aceAa) or isoci-
trate dehydrogenase (icd) were the only genes activated during
nutrient starvation, as well as during survival in mouse lungs.
Additionally, a small number of genes (rv0079, fdxA, rv2028c,
and rv2629) were shared with the exposure to nitric oxide or
hypoxia, implying that at the times examined so far in mice, the
host microenvironment is only partially anaerobic and partially
deficient in nutrients. On the other hand, a relatively high
number of genes identified by IVMA were shared with mac-
rophage survival (see Table S6 and Fig. S2 in the supplemental
material).
To gain more understanding of the chronic stage of human
tuberculosis, we compared the transcriptional levels of M. tu-
berculosis profiled in murine lungs to that profiled in human
lungs (31). However, such analysis could be complicated by the
clinical variations observed in murine compared to human
tuberculosis, as well as the differences in sampling strategies
from patients with multiple-drug regimens and unknown stages
of infection compared to the precise time points examined in
mice by IVMA. Generally, a surprising number of genes (n 
58) regulated in mice were shared with the human samples (see
Table S6 and Fig. S2 in the supplemental material). Overall,
the comparative analysis of IVMA in murine lungs and in vitro
and other models of infection revealed a microenvironment
that is not limited in nutrients or oxygen, consistent with earlier
analysis of mouse lungs (45), but definitely rich in immune
cells, such as macrophages. In conclusion, the IVMA reported
here provided a dynamic view of the changes in mycobacterial
bacilli during both chronic and reactivation stages of infection.
Transcriptional profiling further assisted the dissection of
chronic tuberculosis into early, middle, and late chronic stages,
with a unique transcriptional profile for each stage. The IVMA
approach has begun to identify gene groups activated only
during the reactivation stage of infection, a stage for which
little information is available. Currently, experiments are un-
der way to inactivate specific genes identified during this in-
vestigation (e.g., rv0348) to better characterize their roles in
the chronic and reactivation phases of tuberculosis. The knowl-
edge gained from such an approach will allow investigators to
target novel pathways for chemotherapies to treat chronic tu-
berculosis.
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